.possible depletion of one or more types of blood cells.the prevalence of opportunistic infections that occurs during the treatment.fever and chills, nausea and vomiting, diarrhea, shortness of breath, skin rash, and unusual fatigue.
There have been no formal drug interaction studies done for alemtuzumab.
Alemtuzumab is sold as Campath in the United States
Alemtuzumab is a humanized monoclonal antibody that selectively binds to CD52.that is used to reduce the numbers of circulating malignant cells of patients who have B-cell chronic lymphocytic leukemia (B-CLL).Alemtuzumab is sold as Campath
Blood studies should be done on a weekly basis while patients are receiving the alemtuzumab treatment.Vaccination during the treatment session is not recommended.use during pregnancy and breastfeeding is not recommended unless clearly needed.
Alemtuzumab is a monoclonal antibody used to treat B-CLL.limited success in the treatment of non-Hodgkin's lymphoma (NHL) and for the preparation of patients with various immune cell malignancies for bone marrow transplantation.
I don't think so
What is in Somacid and what are the side effects?
side effects of paroextine
What are the side effects of somatropinne?
What is tabaco side effects
no side effects
wot are the side effects of effergin